Data for this mutation
| Sample ID | MSH2 | MLH1 | MSH6 | MUTYH | APC |
|---|---|---|---|---|---|
| 2_02-DDM6018_24616_24616 | c.638_639delTG (p.Leu213GlnfsX18) | - | - | - | - |
| 6_609051_B67182_S6550 | - | - | - | - | - |
| 8_F1020_B041236_04-0796 | - | - | - | - | - |
| Analysis | Result | Date | Origin | PMID/dbSNP |
|---|---|---|---|---|
| Clinical phenotype | Amsterdam II + (DDM6018) | 16/12/14 | 2 (Villejuif) | |
| MMR function in tumor cells | MSH2-MSH6- (DDM6018-24616) | 28/03/11 | 2 (Villejuif) | |
| Ex vivo analysis | Splicing reporter minigene pCAS: normal splicing (loss of a cryptic splicing site in exon 2) | 7/06/07 | 19 (INSERM U1079-Rouen) | |
| Co-occurrence | MSH2 : c.638_639del, p.Leu213GlnfsX18 (DDM6018-24616) | 28/03/11 | 2 (Villejuif) |
| Biological significance | Date | Comment |
|---|---|---|
| UV | 9/07/15 | --- |